Skip to main content
SpringerLink
Log in

Risk Factors for Hemorrhagic Stroke

  • Chapter
  • First Online:
Stroke Revisited: Hemorrhagic Stroke

Part of the book series: Stroke Revisited ((STROREV))

  • 2097 Accesses

Abstract

Hemorrhagic stroke accounts for approximately 5–15% of all acute stroke events worldwide, with its two most common subtypes being intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Each of these hemorrhagic stroke subtypes accounts for 5–10% of all strokes, with noticeable variations in incidence across geographic regions and racial/ethnic groups. Despite significant advancements in neurocritical care and preventative strategies, morbidity and mortality related to ICH and SAH continue to represent a substantial public health problem worldwide. Indeed, despite accounting for a minority of stroke cases, hemorrhagic stroke accounts for almost half of all stroke-related morbidity and mortality. An in-depth understanding of the genetic, personal, and environmental risk factors influencing hemorrhagic stroke risk will be crucial to implementing novel, effective primary and secondary prevention strategies aimed at preserving lives and preventing disability among at-risk individuals. This chapter will focus on presenting existing evidence on risk factors for ICH and SAH, aiming at providing a critical review of published studies and highlighting current unresolved epidemiological questions pertaining to hemorrhagic stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450–60.

    Article  CAS  PubMed  Google Scholar 

  2. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.

    Article  PubMed  Google Scholar 

  3. Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011;7:1–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Biffi A, Anderson C, Battey TW, et al. Association between blood pressure control and risk of recurrent intracerebral hemorrhage. JAMA. 2015;314(9):904–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Rost NS, Greenberg SM, Rosand J. The genetic architecture of intracerebral hemorrhage. Stroke. 2008;39:2166–73.

    Article  PubMed  Google Scholar 

  6. Woo D, Sekar P, Chakraborty R, et al. Genetic epidemiology of intracerebral hemorrhage. J Stroke Cerebrovasc. 2005;14:239–43.

    Article  Google Scholar 

  7. Devan WJ, Falcone GJ, Anderson CD, et al. Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke. 2013;44:1578–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68:934–43.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Biffi A, Shulman JM, Jagiella JM, et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012;78:334–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Valant V, Keenan B, Anderson C, et al. TOMM40 in cerebral amyloid angiopathy related intracerebral hemorrhage: comparative genetic analysis with Alzheimer’s disease. Transl Stroke Res. 2012;3(Suppl 1):S102–12.

    Article  CAS  Google Scholar 

  11. Hamaguchi T, Okino S, Sodeyama N, et al. Association of a polymorphism of the transforming growth factor-{beta}1 gene with cerebral amyloid angiopathy. J Neurol Neurosur Ps. 2005;76:696–9.

    Article  CAS  Google Scholar 

  12. Peila R, Yucesoy B, White LR, et al. A TGF-beta1 polymorphism association with dementia and neuropathologies: the HAAS. Neurobiol Aging. 2007;28:1367–73.

    Article  CAS  PubMed  Google Scholar 

  13. Woo D, Broderick JP. Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. Neurosurg Clin N Am. 2002;13:265–79.

    Article  PubMed  Google Scholar 

  14. Woo D, Falcone GJ, Devan WJ, et al. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet. 2014;94:511–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol. 2011;69:928–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Verhaaren BF, Debette S, Bis JC, et al. Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet. 2015;8:398–409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Raffeld MR, Biffi A, Battey TW, et al. APOE epsilon4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage. Neurology. 2015;85:349–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Volonghi I, Pezzini A, Del Zotto E, et al. Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndrome. Curr Med Chem. 2010;17:1317–24.

    Article  CAS  PubMed  Google Scholar 

  19. Gould DB, Phalan FC, Van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med. 2006;354:1489–96.

    Article  CAS  PubMed  Google Scholar 

  20. Weng YC, Sonni A, Labelle-Dumais C, et al. COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol. 2012;71:470–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Jeanne M, Labelle-Dumais C, Jorgensen J, et al. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet. 2012;90:91–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rannikmae K, Davies G, Thomson PA, et al. Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Neurology. 2015;84:918–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Poon MT, Bell SM, Al-Shahi Salman R. Epidemiology of intracerebral haemorrhage. Front Neurol Neurosci. 2015;37:1–12.

    Article  PubMed  Google Scholar 

  24. Flaherty ML, Woo D, Haverbusch M, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36:934–7.

    Article  PubMed  Google Scholar 

  25. Labovitz DL, Halim A, Boden-Albala B, et al. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology. 2005;65:518–22.

    Article  CAS  PubMed  Google Scholar 

  26. Woo D, Rosand J, Kidwell C, et al. The ethnic/racial variations of intracerebral hemorrhage (ERICH) study protocol. Stroke. 2013;44:e120–5.

    Article  PubMed  Google Scholar 

  27. Walsh KB, Woo D, Sekar P, et al. Untreated hypertension: a powerful risk factor for lobar and nonlobar intracerebral hemorrhage in whites, blacks, and hispanics. Circulation. 2016;134:1444–52.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hong KS, Bang OY, Kang DW, et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the Korean stroke society and clinical research center for stroke. J Stroke. 2013;15:2–20.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Toyoda K. Epidemiology and registry studies of stroke in Japan. J Stroke. 2013;15:21–6.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Benjamin EJ, Blaha MJ, Chiuve SE et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017; 135:00–00.

    Google Scholar 

  31. Ariesen MJ, Claus SP, Rinkel GJE, et al. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34:2060–5.

    Article  CAS  PubMed  Google Scholar 

  32. Van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.

    Article  PubMed  Google Scholar 

  33. Zia E, Pessah-Rasmussen H, Khan FA, et al. Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. Cerebrovasc Dis. 2006;21:18–25.

    Article  PubMed  Google Scholar 

  34. Martini SR, Flaherty ML, Brown WM, et al. Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology. 2012;79:2275–82.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Jackson CA, Sudlow CLM. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? J Neurol Neurosurg. 2006;77:1244–52.

    Article  CAS  Google Scholar 

  36. Rothwell PM, Howard SC, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469–80.

    Article  CAS  PubMed  Google Scholar 

  37. Jolink WM, Klijn CJ, Brouwers PJ, et al. Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology. 2015;85:1318–24.

    Article  PubMed  Google Scholar 

  38. Lionakis N, Mendrinos D, Sanidas E, et al. Hypertension in the elderly. World J Cardiol. 2012;4:135–47.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Larsson SC, Wallin A, Wolk A, et al. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med. 2016;14:178.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112–7.

    Article  CAS  PubMed  Google Scholar 

  41. Gorelick PB, Kelly MA. Alcohol as a risk factor for stroke. Heart Dis Stroke. 1992;1:255–8.

    PubMed  CAS  Google Scholar 

  42. Thrift AG, Mcneil JJ, Forbes A, et al. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne risk factor study (MERFS) group. Stroke. 1996;27:2020–5.

    Article  CAS  PubMed  Google Scholar 

  43. Giroud M, Creisson E, Fayolle H, et al. Risk factors for primary cerebral hemorrhage: a population-based study—the stroke registry of Dijon. Neuroepidemiology. 1995;14:20–6.

    Article  CAS  PubMed  Google Scholar 

  44. Iribarren C, Jacobs DR, Sadler M, et al. Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? Stroke. 1996;27:1993–8.

    Article  CAS  PubMed  Google Scholar 

  45. Segal AZ, Chiu RI, Eggleston-Sexton PM, et al. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology. 1999;18:185–93.

    Article  CAS  PubMed  Google Scholar 

  46. Yano K, Reed DM, Maclean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu heart program. Stroke. 1989;20:1460–5.

    Article  CAS  PubMed  Google Scholar 

  47. Wang X, Dong Y, Qi X, et al. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke. 2013;44:1833–9.

    Article  CAS  PubMed  Google Scholar 

  48. Xie L, Wu W, Chen J, et al. Cholesterol levels and hemorrhagic stroke risk in east Asian versus non-east Asian populations: a systematic review and meta-analysis. Neurologist. 2017;22:107–15.

    Article  PubMed  Google Scholar 

  49. Mckinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 2012;43:2149–56.

    Article  CAS  PubMed  Google Scholar 

  50. Pandit AK, Kumar P, Kumar A, et al. High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis. Acta Neurol Scand. 2016;134:22–8.

    Article  CAS  PubMed  Google Scholar 

  51. Bos MJ, Koudstaal PJ, Hofman A, et al. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam study. Stroke. 2007;38:3127–32.

    Article  PubMed  Google Scholar 

  52. Ovbiagele B, Wing JJ, Menon RS, et al. Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage. Stroke. 2013;44:2409–13.

    Article  PubMed  Google Scholar 

  53. Kim SH, Shin DW, Yun JM, et al. Kidney dysfunction and cerebral microbleeds in neurologically healthy adults. PLoS One. 2017;12:e0172210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Hoirisch-Clapauch S, Nardi AE, Gris JC, et al. Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects? Thromb Res. 2014;134:11–6.

    Article  CAS  PubMed  Google Scholar 

  55. Pozzi M, Roccatagliata D, Sterzi R. Drug abuse and intracranial hemorrhage. Neurol Sci. 2008;29(Suppl 2):S269–70.

    Article  PubMed  Google Scholar 

  56. Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med J. 2007;83:389–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Mcevoy AW, Kitchen ND, Thomas DG. Intracerebral haemorrhage and drug abuse in young adults. Brit J Neurosurg. 2000;14:449–54.

    Article  CAS  Google Scholar 

  58. Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880–4.

    Article  CAS  PubMed  Google Scholar 

  59. Flaherty ML, Haverbusch M, Sekar P, et al. The increasing burden of anticoagulant-associated intracerebral hemorrhage. Stroke. 2006;37:623.

    Google Scholar 

  60. Shireman TI, Howard PA, Kresowik TF, et al. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke. 2004;35:2362–7.

    Article  CAS  PubMed  Google Scholar 

  61. An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19:3–10.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Charidimou A, Shoamanesh A, Al-Shahi Salman R, et al. Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: the need for a balanced approach. Int J Stroke. 2018;13:117–20.

    Article  PubMed  Google Scholar 

  63. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.

    Article  PubMed  Google Scholar 

  64. Gorelick PB. Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation? Stroke. 2007;38:1652–4.

    Article  PubMed  Google Scholar 

  65. Investigators A, Connolly SJ, Pogue J, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066–78.

    Article  Google Scholar 

  66. Covassin N, Somers VK. Sleep apnea, hypertension, and hemorrhagic stroke-deja vu all over again. J Am Soc Hypertens. 2016;10:197–200.

    Article  PubMed  Google Scholar 

  67. Floras JS. Hypertension and sleep apnea. Can J Cardiol. 2015;31:889–97.

    Article  PubMed  Google Scholar 

  68. Koo DL, Kim JY, Lim JS, et al. Cerebral microbleeds on MRI in patients with obstructive sleep apnea. J Clin Sleep Med. 2017;13:65–72.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia. 2012;32:785–95.

    Article  PubMed  Google Scholar 

  70. Sacco S, Ornello R, Ripa P, et al. Migraine and hemorrhagic stroke: a meta-analysis. Stroke. 2013;44:3032–8.

    Article  PubMed  Google Scholar 

  71. Gaist D, Gonzalez-Perez A, Ashina M, et al. Migraine and risk of hemorrhagic stroke: a study based on data from general practice. J Headache Pain. 2014;15:74.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389:655–66.

    Article  PubMed  Google Scholar 

  73. Broderick JP, Brown RD Jr, Sauerbeck L, et al. Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke. 2009;40:1952–7.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Broderick JP, Sauerbeck LR, Foroud T, et al. Familial intracranial aneurysm (FIA) study protocol. BMC Med Genet. 2005;6(17)

    Google Scholar 

  75. Ruigrok YM, Buskens E, Rinkel GJ. Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke. 2001;32:1173–5.

    Article  CAS  PubMed  Google Scholar 

  76. Alg VS, Sofat R, Houlden H, et al. Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology. 2013;80:2154–65.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Yasuno K, Bilguvar K, Bijlenga P, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet. 2010;42:420–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. De Rooij NK, Linn FH, Van Der Plas JA, et al. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg. 2007;78:1365–72.

    Article  Google Scholar 

  79. Eden SV, Meurer WJ, Sanchez BN, et al. Gender and ethnic differences in subarachnoid hemorrhage. Neurology. 2008;71:731–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Algra AM, Klijn CJ, Helmerhorst FM, et al. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology. 2012;79:1230–6.

    Article  PubMed  Google Scholar 

  81. Kim CK, Kim BJ, Ryu WS, et al. Impact of smoking cessation on the risk of subarachnoid haemorrhage: a nationwide multicentre case control study. J Neurol Neurosurg. 2012;83:1100–3.

    Article  Google Scholar 

  82. Lindekleiv H, Sandvei MS, Njolstad I, et al. Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: a cohort study. Neurology. 2011;76:637–43.

    Article  CAS  PubMed  Google Scholar 

  83. Lindekleiv H, Sandvei MS, Romundstad PR, et al. Joint effect of modifiable risk factors on the risk of aneurysmal subarachnoid hemorrhage: a cohort study. Stroke. 2012;43:1885–9.

    Article  PubMed  Google Scholar 

  84. Andreasen TH, Bartek J Jr, Andresen M, et al. Modifiable risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 2013;44:3607–12.

    Article  PubMed  Google Scholar 

  85. Yoon BW, Bae HJ, Hong KS, et al. Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke. Neurology. 2007;68:146–9.

    Article  CAS  PubMed  Google Scholar 

  86. Lee SM, Choi NK, Lee BC, et al. Caffeine-containing medicines increase the risk of hemorrhagic stroke. Stroke. 2013;44:2139–43.

    Article  CAS  PubMed  Google Scholar 

  87. Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36:2773–80.

    Article  PubMed  Google Scholar 

  88. Kawate N, Kayaba K, Hara M, et al. Body mass index and incidence of subarachnoid hemorrhage in Japanese community residents: the Jichi medical school cohort study. J Stroke Cerebrovasc. 2017;26:1683–8.

    Article  Google Scholar 

  89. Phan K, Moore JM, Griessenauer CJ, et al. Aspirin and risk of subarachnoid hemorrhage: systematic review and meta-analysis. Stroke. 2017;48:1210–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Stroke, Memory Disorders and Behavioral Neurology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Alessandro Biffi

Authors
  1. Alessandro Biffi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Biffi .

Editor information

Editors and Affiliations

  1. Department of Neurology, Seoul National University Hospital Department of Neurology, Seoul, Korea (Republic of)

    Seung-Hoon Lee

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Biffi, A. (2018). Risk Factors for Hemorrhagic Stroke. In: Lee, SH. (eds) Stroke Revisited: Hemorrhagic Stroke. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1427-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1427-7_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1426-0

  • Online ISBN: 978-981-10-1427-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation